mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for CCM2
Gene summary
Basic gene Info.Gene symbolCCM2
Gene namecerebral cavernous malformation 2
SynonymsC7orf22|OSM
CytomapUCSC genome browser: 7p13
Type of geneprotein-coding
RefGenesNM_001029835.2,
NM_001167934.1,NM_001167935.1,NM_031443.3,NR_030770.1,
Descriptioncerebral cavernous malformations 2 proteinmalcavernin
Modification date20141219
dbXrefs MIM : 607929
HGNC : HGNC
Ensembl : ENSG00000136280
HPRD : 09719
Vega : OTTHUMG00000129246
ProteinUniProt: Q9BSQ5
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_CCM2
BioGPS: 83605
PathwayNCI Pathway Interaction Database: CCM2
KEGG: CCM2
REACTOME: CCM2
Pathway Commons: CCM2
ContextiHOP: CCM2
ligand binding site mutation search in PubMed: CCM2
UCL Cancer Institute: CCM2
Assigned class in mutLBSgeneDBC: This gene just belongs to mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID


Top
Ligand binding site mutations for CCM2
Lollipop-style diagram of mutations at LBS in amino-acid sequence.
We represented ligand binding site mutations only. (You can see big image via clicking.)
 
: non-synonymous mutation on LBS, Circle size denotes number of samples.

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
R307R307HBRCA1
F17P16LLUAD1
S312S311LLUSC1
P82L80MSTAD1
R307R307HUCEC1
E207A206VUCEC1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for CCM2
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
R307R307H-1.3091567
P82L80M-0.66187172
E207A206V-0.29251599
S312S311L-0.29020831
F17P16L-0.24628127
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for CCM2 from PDB

Top
Differential gene expression and gene-gene network for CCM2
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of CCM2 and the right PPI network was created from samples without mutations in the LBS of CCM2. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for CCM2
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type
umls:C1864041Cerebral Cavernous Malformations 22Biomarker, GeneticVariation
umls:C0752160Hemangioma, Cavernous, Central Nervous System1Biomarker

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for CCM2
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of CCM2 go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS
IIIPeptide ligand (VAL,ASP,LYS,VAL,VAL,ILE,ASN,PRO,TYR,PHE,GLY)4wj7AP82
IIIPeptide ligand (VAL,ASP,LYS,VAL,VAL,ILE,ASN,PRO,TYR,PHE,GLY,LEU)4wj7BP82
IIIPeptide ligand (VAL,ASP,LYS,VAL,VAL,ILE,ASN,PRO,TYR,PHE,GLY)4wj7CP82 E207
IIIPeptide ligand (VAL,ASP,LYS,VAL,VAL,ILE,ASN,PRO,TYR,PHE,GLY)4wj7DP82 E207
IIIPeptide ligand (ASP,GLU,GLN,GLU,ALA,LEU,ASN,SER,ILE,MET,ASN,ASP,LEU,VAL,ALA,LEU,GLN,MET)4yl6AR307 S312


Top
Conservation information for LBS of CCM2
Multiple alignments for Q9BSQ5 in multiple species
LBSAA sequence# speciesSpecies
A140PIHDIAAVSYV2Homo sapiens, Mus musculus
A140PIHDIAAVSYI1Danio rerio
A141IHDIAAVSYVR2Homo sapiens, Mus musculus
A141IHDIAAVSYIR1Danio rerio
A319EIQQFAALLHE2Homo sapiens, Mus musculus
A319EIQQFATLLHE1Danio rerio
C210AAEELCCLLGQ1Homo sapiens
C210AAEELCLLLSQ1Danio rerio
C210AAEELCSLLSQ1Mus musculus
C211AEELCCLLGQV1Homo sapiens
C211AEELCLLLSQV1Danio rerio
C211AEELCSLLSQV1Mus musculus
D138RVPIHDIAAVS3Homo sapiens, Danio rerio, Mus musculus
E207SKVAAEELCCL1Homo sapiens
E207NKAAAEELCLL1Danio rerio
E207SKVAAEELCSL1Mus musculus
F17GIVSPFKRVFL3Homo sapiens, Danio rerio, Mus musculus
F217LLSQVFQIVYT2Danio rerio, Mus musculus
F217LLGQVFQVVYT1Homo sapiens
F318QEIQQFAALLH2Homo sapiens, Mus musculus
F318KEIQQFATLLH1Danio rerio
F356LGLRPFIPEKD3Homo sapiens, Danio rerio, Mus musculus
G214LCCLLGQVFQV1Homo sapiens
G214LCLLLSQVFQI1Danio rerio
G214LCSLLSQVFQI1Mus musculus
H137LRVPIHDIAAV3Homo sapiens, Danio rerio, Mus musculus
H323FAALLHEYRNG2Homo sapiens, Mus musculus
H323FATLLHEYRNG1Danio rerio
I136ILRVPIHDIAA3Homo sapiens, Danio rerio, Mus musculus
I139VPIHDIAAVSY3Homo sapiens, Danio rerio, Mus musculus
I315LSSQEIQQFAA2Homo sapiens, Mus musculus
I315LSSKEIQQFAT1Danio rerio
K203LAAESKVAAEE1Homo sapiens
K203LAVDNKAAAEE1Danio rerio
K203MATESKVAAEE1Mus musculus
L299SATELLQDYML2Homo sapiens, Mus musculus
L299TAAELLQDYMT1Danio rerio
L306DYMLTLRTKLS2Homo sapiens, Mus musculus
L306DYMTTLRTKLS1Danio rerio
L322QFAALLHEYRN2Homo sapiens, Mus musculus
L322QFATLLHEYRN1Danio rerio
M303LLQDYMLTLRT2Homo sapiens, Mus musculus
M303LLQDYMTTLRT1Danio rerio
P355LLGLRPFIPEK3Homo sapiens, Danio rerio, Mus musculus
P358LRPFIPEKDSQ3Homo sapiens, Danio rerio, Mus musculus
P82PGYLNPSSRTE3Homo sapiens, Danio rerio, Mus musculus
Q316SSQEIQQFAAL2Homo sapiens, Mus musculus
Q316SSKEIQQFATL1Danio rerio
R146AVSYVRDDAAH2Homo sapiens, Mus musculus
R146AVSYIRDDSLH1Danio rerio
R307YMLTLRTKLSS2Homo sapiens, Mus musculus
R307YMTTLRTKLSS1Danio rerio
R326LLHEYRNGASI3Homo sapiens, Danio rerio, Mus musculus
R85LNPSSRTEILH2Homo sapiens, Mus musculus
R85LNPSSRTEVLQ1Danio rerio
S143DIAAVSYVRDD2Homo sapiens, Mus musculus
S143DIAAVSYIRDD1Danio rerio
S312RTKLSSQEIQQ2Homo sapiens, Mus musculus
S312RTKLSSKEIQQ1Danio rerio
S83GYLNPSSRTEI2Homo sapiens, Mus musculus
S83GYLNPSSRTEV1Danio rerio
S84YLNPSSRTEIL2Homo sapiens, Mus musculus
S84YLNPSSRTEVL1Danio rerio
V14KKPGIVSPFKR3Homo sapiens, Danio rerio, Mus musculus
V142HDIAAVSYVRD2Homo sapiens, Mus musculus
V142HDIAAVSYIRD1Danio rerio
V145AAVSYVRDDAA2Homo sapiens, Mus musculus
V145AAVSYIRDDSL1Danio rerio
V45RPLHTVVLSLP1Homo sapiens
V45RALHTFSLSLP1Danio rerio
V45RPLHTVVLALP1Mus musculus
Y144IAAVSYVRDDA2Homo sapiens, Mus musculus
Y144IAAVSYIRDDS1Danio rerio
Y325ALLHEYRNGAS2Homo sapiens, Mus musculus
Y325TLLHEYRNGAS1Danio rerio


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas